Role of hepatitis C virus core antigen assay in hepatitis C care in Africa

M Lemoine, Z Mohamed, Stephane CHEVALIEZ, Y Shimakawa, J Rwegasha,

Lancet Gastroenterol Hepatol 01/04/2018;3(4) : 223-224 10.1016/S2468-1253(18)30039-6 07/03/2018

Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: A retrospective study in a developed country

PO Sellier, S Maylin, Ségolène BRICHLER, B Bercot, A Lopes, D Chopin, M Pogliaghi, AL Munier, V Delcey, G Simoneau, J Evans, Emmanuel GORDIEN, F Simon, JF Bergmann,

Liver Int. 01/04/2018;38(4) : 611-618 10.1111/liv.13556 12/09/2017

Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE

V De Ledinghen, C Laforest, Christophe HEZODE, S Pol, A Renault, L Alric, D Larrey, S Metivier, A Tran, C Jezequel, D Samuel, F Zoulim, C Tual, A Pailhe, S Gibowski, M Bourliere, E Bellissant, Jean-Michel PAWLOTSKY,

Clin Infect Dis. 19/03/2018;66(7) : 1013-1018 10.1093/cid/cix916.

Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study

V De Ledinghen, C Laforest, Christophe HEZODE, S Pol, A Renault, L Alric, D Larrey, S Metivier, A Tran, C Jezequel, D Samuel, F Zoulim, C Tual, A Pailhe, S Gibowski, M Bourliere, E Bellissant, Jean-Michel PAWLOTSKY,

Clin Infect Dis. 19/03/2018;66(7) : 1013-1018 10.1093/cid/cix916.

Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives.

A Schernberg, E Rivin Del Campo, Benoit ROUSSEAU, O Matzinger, M Loi, P Maingon, F Huguet,

Clin Transl Radiat Oncol. 13/03/2018;10 : 13-22 10.1016/j.ctro.2018.02.005 01/03/2018

A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination.

Christophe RODRIGUEZ, Alexandre SOULIER, Vanessa DEMONTANT, Lila POITEAU, Mélanie MERCIER-DARTY, Magali BOUVIER-ALIAS, Jean-Michel PAWLOTSKY, Stephane CHEVALIEZ,

Sci Rep. 08/03/2018;8(1) : 4180 10.1038/s41598-018-22614-0.

Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.

Mélanie MERCIER-DARTY, D Boutolleau, R Lepeule, Christophe RODRIGUEZ, S Burrel,

Antiviral Res. 01/03/2018;151 : 20-23 10.1016/j.antiviral.2018.01.008. 12/01/2018

Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor

Slim FOURATI, J Guedj, Stephane CHEVALIEZ, THT Nguyen, F Roudot-Thoraval, Isaac RUIZ, Alexandre SOULIER, G Scoazec, A Varaut, Lila POITEAU, Murielle FRANCOIS, A Mallat, Christophe HEZODE, Jean-Michel PAWLOTSKY,

Aliment Pharmacol Ther. 01/03/2018;47(5) : 665-673 10.1111/apt.14478. 22/12/2017

Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon-free direct-acting antiviral combinations? Authors' reply.

Slim FOURATI, Jean-Michel PAWLOTSKY,

Aliment Pharmacol Ther. 01/03/2018;47(6) : 849-850 10.1111/apt.14520.

Response to "Quantitative analysis of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of llcer method using gadobenate dimeglumine as contrast agent"

M Roux, F Pigneur, Alain LUCIANI,

J Magn Reson Imaging. 01/03/2018;47(3) : 862-863 10.1002/jmri.25788 05/06/2017